Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells

Qin Wang,1,* Fangcen Liu,2,* Lifeng Wang,1 Chen Xie,3 Puyuan Wu,1 Shiyao Du,1 Shujuan Zhou,1 Zhichen Sun,1 Qin Liu,1 Lixia Yu,1 Baorui Liu,1 Rutian Li1 1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanj...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang Q, Liu F, Wang L, Xie C, Wu P, Du S, Zhou S, Sun Z, Liu Q, Yu L, Liu B, Li R
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/0b658a021cfa42d5b0ddbec2b0d66c36
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0b658a021cfa42d5b0ddbec2b0d66c36
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic nanoparticles
salinomycin
tumor targeted delivery
cancer stem cells
epithelial interstitial transformation;
Medicine (General)
R5-920
spellingShingle nanoparticles
salinomycin
tumor targeted delivery
cancer stem cells
epithelial interstitial transformation;
Medicine (General)
R5-920
Wang Q
Liu F
Wang L
Xie C
Wu P
Du S
Zhou S
Sun Z
Liu Q
Yu L
Liu B
Li R
Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
description Qin Wang,1,* Fangcen Liu,2,* Lifeng Wang,1 Chen Xie,3 Puyuan Wu,1 Shiyao Du,1 Shujuan Zhou,1 Zhichen Sun,1 Qin Liu,1 Lixia Yu,1 Baorui Liu,1 Rutian Li1 1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing 210008, People’s Republic of China; 2The Comprehensive Cancer Centre, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, People’s Republic of China; 3Key Laboratory for Organic Electronics and Information Displays, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, Nanjing 210023, People’s Republic of China*These authors contributed equally to this workCorrespondence: Rutian Li; Baorui LiuThe Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing 210008, People’s Republic of ChinaTel +86-25-83107081Fax +86-25-83317016Email rutianli@nju.edu.cn; baoruiliu@nju.edu.cnBackground: Cervical cancer stem cells (CCSCs) represent a subpopulation of tumor cells that possess self-renewal capacity and numerous intrinsic mechanisms of resistance to conventional chemotherapy and radiotherapy. These cells play a crucial role in relapse and metastasis of cervical cancer. Therefore, eradication of CCSCs is the primary objective in cervical cancer therapy. Salinomycin (Sal) is an agent used for the elimination of cancer stem cells (CSCs); however, the occurrence of several side effects hinders its application. Nanoscale drug-delivery systems offer great promise for the diagnosis and treatment of tumors. These systems can be used to reduce the side effects of Sal and improve clinical benefit.Methods: Sal-loaded polyethylene glycol-peptide-polycaprolactone nanoparticles (Sal NPs) were fabricated under mild and non-toxic conditions. The real-time biodistribution of Sal NPs was investigated through non-invasive near-infrared fluorescent imaging. The efficacy of tumor growth inhibition by Sal NPs was evaluated using tumor xenografts in nude mice. Flow cytometry, immunohistochemistry, and Western blotting were used to detect the apoptosis of CSCs after treatment with Sal NPs. Immunohistochemistry and Western blotting were used to examine epithelial–mesenchymal transition (epithelial interstitial transformation) signal-related molecules.Results: Sal NPs exhibited antitumor efficacy against cervical cancers by inducing apoptosis of CCSCs and inhibiting the epithelial–mesenchymal transition pathway. Besides, tumor pieces resected from Sal NP-treated mice showed decreased reseeding ability and growth speed, further demonstrating the significant inhibitory ability of Sal NPs against CSCs. Moreover, owing to targeted delivery based on the gelatinase-responsive strategy, Sal NPs was more effective and tolerable than free Sal.Conclusion: To the best of our knowledge, this is the first study to show that CCSC-targeted Sal NPs provide a potential approach to selectively target and efficiently eradicate CCSCs. This renders them a promising strategy to improve the therapeutic effect against cervical cancer.Keywords: nanoparticles, salinomycin, tumor-targeted delivery, cancer stem cells, epithelial interstitial transformation
format article
author Wang Q
Liu F
Wang L
Xie C
Wu P
Du S
Zhou S
Sun Z
Liu Q
Yu L
Liu B
Li R
author_facet Wang Q
Liu F
Wang L
Xie C
Wu P
Du S
Zhou S
Sun Z
Liu Q
Yu L
Liu B
Li R
author_sort Wang Q
title Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
title_short Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
title_full Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
title_fullStr Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
title_full_unstemmed Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
title_sort enhanced and prolonged antitumor effect of salinomycin-loaded gelatinase-responsive nanoparticles via targeted drug delivery and inhibition of cervical cancer stem cells
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/0b658a021cfa42d5b0ddbec2b0d66c36
work_keys_str_mv AT wangq enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT liuf enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT wangl enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT xiec enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT wup enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT dus enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT zhous enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT sunz enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT liuq enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT yul enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT liub enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
AT lir enhancedandprolongedantitumoreffectofsalinomycinloadedgelatinaseresponsivenanoparticlesviatargeteddrugdeliveryandinhibitionofcervicalcancerstemcells
_version_ 1718401651235094528
spelling oai:doaj.org-article:0b658a021cfa42d5b0ddbec2b0d66c362021-12-02T03:36:53ZEnhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells1178-2013https://doaj.org/article/0b658a021cfa42d5b0ddbec2b0d66c362020-02-01T00:00:00Zhttps://www.dovepress.com/enhanced-and-prolonged-antitumor-effect-of-salinomycin-loaded-gelatina-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Qin Wang,1,* Fangcen Liu,2,* Lifeng Wang,1 Chen Xie,3 Puyuan Wu,1 Shiyao Du,1 Shujuan Zhou,1 Zhichen Sun,1 Qin Liu,1 Lixia Yu,1 Baorui Liu,1 Rutian Li1 1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing 210008, People’s Republic of China; 2The Comprehensive Cancer Centre, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, People’s Republic of China; 3Key Laboratory for Organic Electronics and Information Displays, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, Nanjing 210023, People’s Republic of China*These authors contributed equally to this workCorrespondence: Rutian Li; Baorui LiuThe Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing 210008, People’s Republic of ChinaTel +86-25-83107081Fax +86-25-83317016Email rutianli@nju.edu.cn; baoruiliu@nju.edu.cnBackground: Cervical cancer stem cells (CCSCs) represent a subpopulation of tumor cells that possess self-renewal capacity and numerous intrinsic mechanisms of resistance to conventional chemotherapy and radiotherapy. These cells play a crucial role in relapse and metastasis of cervical cancer. Therefore, eradication of CCSCs is the primary objective in cervical cancer therapy. Salinomycin (Sal) is an agent used for the elimination of cancer stem cells (CSCs); however, the occurrence of several side effects hinders its application. Nanoscale drug-delivery systems offer great promise for the diagnosis and treatment of tumors. These systems can be used to reduce the side effects of Sal and improve clinical benefit.Methods: Sal-loaded polyethylene glycol-peptide-polycaprolactone nanoparticles (Sal NPs) were fabricated under mild and non-toxic conditions. The real-time biodistribution of Sal NPs was investigated through non-invasive near-infrared fluorescent imaging. The efficacy of tumor growth inhibition by Sal NPs was evaluated using tumor xenografts in nude mice. Flow cytometry, immunohistochemistry, and Western blotting were used to detect the apoptosis of CSCs after treatment with Sal NPs. Immunohistochemistry and Western blotting were used to examine epithelial–mesenchymal transition (epithelial interstitial transformation) signal-related molecules.Results: Sal NPs exhibited antitumor efficacy against cervical cancers by inducing apoptosis of CCSCs and inhibiting the epithelial–mesenchymal transition pathway. Besides, tumor pieces resected from Sal NP-treated mice showed decreased reseeding ability and growth speed, further demonstrating the significant inhibitory ability of Sal NPs against CSCs. Moreover, owing to targeted delivery based on the gelatinase-responsive strategy, Sal NPs was more effective and tolerable than free Sal.Conclusion: To the best of our knowledge, this is the first study to show that CCSC-targeted Sal NPs provide a potential approach to selectively target and efficiently eradicate CCSCs. This renders them a promising strategy to improve the therapeutic effect against cervical cancer.Keywords: nanoparticles, salinomycin, tumor-targeted delivery, cancer stem cells, epithelial interstitial transformationWang QLiu FWang LXie CWu PDu SZhou SSun ZLiu QYu LLiu BLi RDove Medical Pressarticlenanoparticlessalinomycintumor targeted deliverycancer stem cellsepithelial interstitial transformation;Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 1283-1295 (2020)